This statistic depicts the market share of filgrastim attributable to Neupogen and its U.S. biosimilars from 2015 to 2018. In 2015, 83.8 percent of filgrastim sales were attributable to Neupogen. However, as of November 2017, just 60.2 percent of filgrastim sales were attributable to Neupogen.
Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Association for Accessible Medicines, & IQVIA. (February 5, 2019). Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018 [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/
Association for Accessible Medicines, und IQVIA. "Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018." Chart. February 5, 2019. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/
Association for Accessible Medicines, IQVIA. (2019). Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018. Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/
Association for Accessible Medicines, and IQVIA. "Filgrastim Market Share of Neupogen and Its U.S. Biosimilar Competitors from 2015 to 2018." Statista, Statista Inc., 5 Feb 2019, https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/
Association for Accessible Medicines & IQVIA, Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/ (last visited September 20, 2024)
Filgrastim market share of Neupogen and its U.S. biosimilar competitors from 2015 to 2018 [Graph], Association for Accessible Medicines, & IQVIA, February 5, 2019. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/869873/percentage-neupogen-sales-loss-to-biosimilars/